TherapeuticsMD
TXMD
TXMD
140 hedge funds and large institutions have $711M invested in TherapeuticsMD in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
140
Holders Change
-15
Holders Change %
-9.68%
% of All Funds
3.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
47
Reduced
43
Closed
34
Calls
$1.92M
Puts
$1.67M
Net Calls
+$254K
Net Calls Change
-$1.36M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$23M |
| 2 |
Millennium Management
New York
|
+$9.28M |
| 3 |
DCM
Daruma Capital Management
New York
|
+$6.94M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$6.05M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.89M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14.5M |
| 2 |
NC
Nexthera Capital
New York
|
-$8.58M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$5.78M |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$4.92M |
| 5 |
First Eagle Investment Management
New York
|
-$3.78M |
